At a glance
BGIG charges 0.45% a year, below the 0.72% average of the 3 funds most like it (the 2nd cheapest of 4). It has $2.16B in assets, the largest of that group; it paid 1.67% of its price in distributions over the past 12 months, monthly. Over the past year it returned +16.4% with distributions reinvested (S&P 500: +11.5%), the best of those 4 funds; over three years it returned +20.1% a year. Its ten largest positions make up 39.7% of the fund, out of 53 in all.
The short version
Bahl & Gaynor Income Growth ETF (BGIG) is an actively managed fund. As of June 30, 2026, it held 53 large dividend-paying companies, picked by Bahl & Gaynor for dividend growth and business quality. It aims for rising income and smaller losses than the broader stock market. Its 0.45% expense ratio is below the 0.72% average of the similar funds compared here. Its yield is modest, though: 1.67% as of October 27, 2026.
Price history
The interactive chart needs JavaScript.
BGIG +16.4% over the year to Oct 27, 2026, total return with distributions reinvested.
How it has behaved
| YTD | 1 yr | 3 yr | 5 yr | 10 yr | Since start | |
|---|---|---|---|---|---|---|
| BGIG official prospectus, to Dec 31, 2025 | — | +12.39% | — | — | — | +14.24% |
| BGIG price data to Oct 27, 2026 | +16.1% | +16.4% | +20.1% | — | — | +16.2% |
- Over the year to Oct 27, 2026, BGIG returned +16.4%, 1st of 4 among similar funds.
- Its worst full calendar year was 2025 (+12.5%); its best was 2024 (+16.9%).
- The deepest fall in its price history was 13.2% (Oct 18, 2024 to Apr 8, 2025), recovered by Jun 30, 2025.
Show as a table
| Year | Price data | Prospectus (official) |
|---|---|---|
| 2026 (to date) | +16.1% | — |
| 2025 | +12.5% | +12.39% |
| 2024 | +16.9% | +16.87% |
| 2008 financial crisis stocks fell Oct 9, 2007 – Mar 9, 2009 | Before this security existed |
|---|---|
| 2020 COVID crash stocks fell Feb 19, 2020 – Mar 23, 2020 | Before this security existed |
| 2022 bear market stocks fell Jan 3, 2022 – Oct 12, 2022 | Before this security existed |
Dividends and income
Show as a table
| Year | Per share | Change |
|---|---|---|
| 2026 (to date) | $0.4670 | |
| 2025 | $0.6120 | +3.0% |
| 2024 | $0.5940 |
What's inside
As of Jun 30, 2026, the fund held 53 securities; the ten largest made up 39.69% of assets.
| Holding | Weight | |
|---|---|---|
| Broadcom Inc | 4.87% | |
| UnitedHealth Group Inc | 4.84% | |
| Eli Lilly & Co | 4.44% | |
| PNC Financial Services Group I | 4.11% | |
| TSMC | 4.05% | |
| Johnson & Johnson | 4.03% | |
| AbbVie Inc | 3.51% | |
| Microsoft Corp | 3.39% | |
| Williams Cos Inc | 3.26% | |
| Apollo Global Management Inc | 3.19% | |
| JPMorgan Chase & Co | 2.96% | |
| Cisco Systems Inc | 2.80% | |
| Travelers Cos Inc | 2.60% | |
| General Dynamics Corp | 2.41% | |
| NextEra Energy Inc | 2.24% |
By country
United States 88.2%Ireland 4.38%Taiwan 4.05%Switzerland 2.09%United Kingdom 1.31%By asset type
Stocks 99.91%Bonds and notes 0.11%By sector
Sectors of the companies held, for the 84.5% of the fund in companies that have a stock page here; other holdings and cash aren't classified. Source: N-PORT holdings report as of Jun 30, 2026. Cash, money-market funds and derivatives are shown separately from the securities list.What changed recently
- Over the three months to Jun 30, 2026, investors withdrew a net $46.8M (creations minus redemptions, per the N-PORT report).
- Monthly total returns reported for that quarter: +5.45%, +0.56%, +2.27%.
How it works
BGIG does not track an index. Its adviser, Bahl & Gaynor, Inc., picks stocks one company at a time, which is called a bottom-up approach. It looks at each company's record of earnings and dividend growth, its balance sheet, its cash flow, its competitive position and its prospects for raising dividends. The fund mostly buys US-listed companies worth more than $7 billion. It can also hold ADRs, which are US-traded receipts for foreign shares, and REITs, which are companies that own property and pay out most of their income.
The adviser sets each position's size based on its view of the company's fundamentals, its valuation and the economy. The prospectus gives no fixed rebalancing schedule. The adviser generally sells a stock for one of four reasons: the dividend is cut too far, the business or its management weakens, the position grows larger than wanted, or a better opportunity comes along. Portfolio turnover was 28%.
As of June 30, 2026, the largest holdings were Broadcom (4.9%), UnitedHealth Group (4.8%), Eli Lilly (4.4%), PNC Financial (4.1%) and Taiwan Semiconductor (4.0%). The top 10 made up about 40% of the fund, and about 88% was in US companies. The fund held no derivatives, so it uses no options and no leverage. Its picks can pile up in certain sectors. Health care was the largest sector, at 16.8%.
What it really costs
- BGIG charges 0.45% a year, versus an average of 0.72% for the similar funds below (2nd of 4, cheapest first).
- Using the prospectus's standard example, $10,000 invested would cost about $46 in the first year and $567 over 10 years (assuming a 5% annual return).
| Cost of $10,000 (SEC example) | 1 yr | 3 yrs | 5 yrs | 10 yrs |
|---|---|---|---|---|
| BGIG | $46 | $144 | $252 | $567 |
In a retirement portfolio
BGIG pays monthly and aims for steadily rising dividends from large, established companies, though its starting yield is modest.
BGIG pays dividends monthly. Its trailing 12-month yield was 1.67% as of October 27, 2026, so most of its return has come from rising share prices, not income. The fund launched in September 2023. That means it has no record in the 2008, 2020 or 2022 downturns. Its deepest drop was 13.2%, from October 18, 2024 to April 8, 2025. It had recovered by June 30, 2025, about 2.7 months later. It has not had a losing calendar year: per the prospectus, it returned 16.87% in 2024 and 12.39% in 2025. Its one-year beta was 0.47. Beta measures how much a fund moves with the market, so a lower number means smaller swings. Still, three years is a short test for a fund meant to soften losses. Under the SEC's standard $10,000 example, costs come to $46 in the first year. Past results don't predict the future, and a plan should look at the whole portfolio, not one fund.
Who it may suit — and who should look elsewhere
May suit
- Investors who want monthly dividends from large companies picked for dividend growth, and who accept a 1.67% yield (as of October 27, 2026).
- Investors who prefer a manager that sells stocks after deep dividend cuts over a passive index, at 0.45% a year.
- Investors who want stocks with smaller swings: one-year beta was 0.47, and the deepest drop since launch was 13.2%.
Look elsewhere if
- Income seekers who need a high payout: the 1.67% trailing yield is low for a monthly-paying income fund.
- Investors who want a long track record: the fund launched in September 2023 and missed the 2008, 2020 and 2022 bear markets.
- Investors who want broad diversification: it held just 53 stocks, with the top 10 at about 40% of assets (June 30, 2026).
Close alternatives
Matched by holdings overlap from the latest N-PORT reports.
Net assets from each fund's latest N-PORT or annual report where available. Returns through Oct 27, 2026.Questions investors ask
Does BGIG pay monthly dividends?
Yes. BGIG pays dividends monthly. Over the 12 months to October 27, 2026, it paid about $0.62 per share, a trailing yield of 1.67%. That yield is modest. The fund's stated goal is current income that grows over time, not the highest possible payout. It aims to get there by owning large companies with a record of raising dividends, such as Johnson & Johnson, AbbVie and Microsoft.
What is BGIG's expense ratio?
BGIG's expense ratio is 0.45% a year, per its prospectus filed April 22, 2026. All of it is the management fee, and there is no fee waiver. Under the SEC's standard example ($10,000 invested, 5% annual return), you would pay about $46 in the first year, $252 over five years and $567 over 10 years. That is below the 0.72% average of the similar funds compared here.
What are BGIG's top holdings?
As of June 30, 2026, BGIG's largest holdings were Broadcom (4.9%), UnitedHealth Group (4.8%), Eli Lilly (4.4%), PNC Financial (4.1%), Taiwan Semiconductor (4.0%) and Johnson & Johnson (4.0%). The fund held 53 stocks, and the top 10 made up about 40% of assets. Health care was the largest sector at 16.8%, followed by financials at 14.5%. About 88% was in US companies.
BGIG vs TGLR: what's the difference?
Both are actively managed stock-income ETFs, and their holdings overlapped by about 30%. BGIG costs 0.45% a year, while LAFFER TENGLER Equity Income ETF (TGLR) costs 0.95%. BGIG is also far larger: $2.16 billion in net assets as of June 30, 2026, against TGLR's $27 million as of January 31, 2026. As of October 27, 2026, BGIG returned 16.4% over one year versus TGLR's 9.2%. Over three years, TGLR led, at 22.9% a year versus 20.1%.
Is BGIG good for retirement income?
It can supply part of a retirement income stream, but the yield is modest: 1.67% as of October 27, 2026, paid monthly. The fund aims for growing dividends and smaller losses than the broader market. Its deepest drop was 13.2%, and it recovered in about 2.7 months. But it launched in September 2023, so it has never been tested in a long bear market. It may suit retirees who want dividend growth more than a high starting yield.